Tham Ji C, le Roux Carel W, Docherty Neil G
Musgrove Park Hospital, Taunton, UK.
Curr Cardiol Rep. 2015 May;17(5):34. doi: 10.1007/s11886-015-0588-6.
Obesity is associated with significant increases in morbidity and mortality secondary, in part, to the increased burden of cardiovascular and renal diseases. Currently, bariatric surgery represents an important component of intensive approaches to the treatment of chronic and complex obesity. The efficacy of bariatric surgery extends beyond its ability to support significant and sustainable reductions in bodyweight to improvements in metabolic and cardiovascular health which are proposed to occur, in part, via weight loss-independent physiological changes. This report summarises the concept of cardiovascular and renal diseases as important constituent aspects of obese morbidity that contribute to overall impairments in health and lifespan. It furthermore describes the key features of bariatric surgical interventions, the evidence base for their beneficial effect on cardiovascular and renal diseases, and lastly provides some perspectives on the mechanisms involved.
肥胖与发病率和死亡率的显著增加相关,部分原因是心血管和肾脏疾病负担的加重。目前,减肥手术是治疗慢性复杂性肥胖的强化方法的重要组成部分。减肥手术的疗效不仅体现在能够显著且持续地减轻体重,还能改善代谢和心血管健康,部分原因是通过与体重减轻无关的生理变化实现的。本报告总结了心血管和肾脏疾病作为肥胖发病率重要组成部分的概念,这些疾病导致了整体健康和寿命的损害。此外,它还描述了减肥手术干预的关键特征、其对心血管和肾脏疾病有益作用的证据基础,最后提供了一些关于所涉及机制的观点。